Point & Figure Pulse
Published: October 28, 2025
This content is for informational purposes only. This should not be construed as solicitation. The general public should consult their financial advisor for additional information related to investment decisions.
Emerging markets’ recent rally has been positive enough to cause the RS chart between EFA and EEM to reverse down into a column of Os, favoring emerging markets for the first time since 2021.

Through the first month of Q4, emerging markets have outpaced their developed market counterparts by more than 1.5% (thru 10/27) looking at the iShares MSCI Emerging Markets ETF (EEM) and iShares MSCI EAFE ETF (EFA). This continues a trend that began in Q3, though both have improved on recent highs with EFA trading at all-time highs and EEM at fresh 52-week highs. EEM has simply outpaced EFA and the broader market in recent months, leading EEM to a stellar fund score of 5.61, while EFA’s is still a strong 4.4. The notable difference between the two ETFs’ fund scores lies in EEM giving a market RS buy signal against the S&P 500 Equal Weight Index (SPXEWI) back in September, while EFA maintains a market RS sell signal given back in December 2009.  

Emerging markets’ recent rally has been positive enough comparatively to developed markets to cause the RS chart between EFA and EEM to reverse down into a column of Os. Prior to the reversal into Os on 10/27, the chart had been in a column of Xs since May 2021, highlighting developed markets during that period with EFA outperforming EEM by more than 17% (5/5/2021 – 10/27/2025). With the inverse RS chart of EEM vs. EFA having been in Xs since late September, the EFA vs. EEM RS chart reversal offers further confirmation of emerging markets superior performance in the near-term.

While the EFA vs. EEM RS chart (as well as its inverse) continue to favor developed markets (EFA) in the long-term, the reversals to favor emerging markets during the short-term gives enough evidence to add more emerging markets exposure to an international allocation.

Back to report

DISCLOSURE

This report is for Internal Use Only and not for distribution to the public. While we make every effort to be free of errors in this report, it contains data obtained from other sources. We believe these sources to be reliable, but we cannot guarantee their accuracy. Investors who use options should read the Options Disclosure Document before making any particular investment decision. Officers or employees of this firm may now or in the future have a position in the stocks mentioned in this report. Dorsey, Wright is a Registered Investment Advisor with the U.S. Securities & Exchange Commission. Copies of Form ADV Part II are available upon request.
Equity prices provided by Thomson-Reuters. Cross Rate prices provided by Tenfore Systems. Option prices provided by OPRA
Copyright © 1995-{ENDYEAR} Dorsey, Wright & Associates, LLC.®
All quotes displayed are delayed 20 minutes
Disclaimer/Terms of Use/Copyright